Cancer research reveals blood tests can detect tumor-derived mutations years before diagnosis. Johns Hopkins scientists ...

Early cancer detection often leads to less aggressive treatments, reduced recovery times and higher survival rates.

A new study using one of the world's largest cancer registries shows that patient outcomes can be significantly impacted ...

While testing of colorectal cancer tumors for mismatch repair (MMR) defects has been recommended for years, the majority of ...

Colorectal cancer highlights from ASCO 2025 include findings from the BREAKWATER, ATOMIC, DYNAMIC-III, and TRIPLETE trials.

Doctors are recommending an alternative test to colonoscopies for people who are at average risk of colon cancer.

Black Americans have the highest death rate and shortest survival for most cancers, including breast, prostate, lung and ...

Let’s make June a turning point where more people get screened, more cancers are caught early and fewer lives are lost.

The clinical lab giant is working with MD Anderson on an LDT for assessing cancer risk to drive uptake of recommended screenings and identify high-risk individuals for evaluation.

The feasibility stage will test the chosen biomarkers and machine learning-based algorithm in actual clinical blood samples.

The early colorectal cancer test will be developed using Tagomics’ Interlace platform for identifying DNA-based biomarkers.